期刊
STEM CELLS
卷 29, 期 6, 页码 981-991出版社
WILEY
DOI: 10.1002/stem.646
关键词
Strontium; Mesenchymal stem cells; Wnt/beta-Catenin
资金
- National Natural Science Foundation of China (NSFC) [30970942, 30900594, 81000551]
- National Basic Research Program of China (973 program) [2009CB526501, 2010CB529605]
- Chinese Academy of Science
- Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies
- Shenzhen Governmental Basic Research Grant
Strontium ranelate is a newly approved drug that can reduce the risk of vertebral fracture, which is attributed to its dual function in increasing the bone formation and decreasing the bone resorption. Strontium-containing hydroxyapatite was also demonstrated to stimulate the osteoblast activity and inhibit the osteoclast activity. However, the molecular mechanisms of strontium underlying such beneficial effects were still not fully understood. In this study, we investigated the effects of strontium on the osteogenic differentiation of human mesenchymal stem cells (MSCs) and its related mechanism; its osteogenic potential was also evaluated using a calvarial defect model in rats. We found that strontium could enhance the osteogenic differentiation of the MSCs, with upregulated extracellular matrix (ECM) gene expression and activated Wnt/beta-catenin pathway. After transplanting the collagen-strontium-substituted hydroxyapatite scaffold into the bone defect region, histology and computed tomography scanning revealed that in vivo bone formation was significantly enhanced; the quantity of mature and remodeled bone substantially increased and ECM accumulated. Interestingly, strontium induced an increase of beta-catenin expression in newly formed bone area. In this study, we showed for the first time that strontium could stimulate the beta-catenin expression in vitro and in vivo, which might contribute to the enhanced osteogenic differentiation of MSCs and in vivo bone formation. STEM CELLS 2011;29:981-991
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据